Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 1, 2016, Pages 256-264

  Wubetu, Gizachew Y ^a   Shimada, Mitsuo ^a   Morine, Yuji ^a   Ikemoto, Tetsuya ^a   Ishikawa, Daichi ^a   Iwahashi, Shuichi ^a   Yamada, Shinichiro ^a   Saito, Yu ^a   Arakawa, Yusuke ^a   Imura, Satoru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cancer sphere; Cancer stem cell; Colon; Epigallocatechin gallate; Hepatoma

Indexed keywords

ABC TRANSPORTER; EPIGALLOCATECHIN GALLATE; PROTEIN DERIVATIVE; PROTEIN NEK2; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CATECHIN; TEA;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL RENEWAL; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GROWTH INHIBITION; HCT116 CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WST-8 ASSAY; ANALOGS AND DERIVATIVES; CANCER STEM CELL; CELL PROLIFERATION; COLON TUMOR; DOSE RESPONSE; DRUG EFFECTS; LIVER TUMOR; PATHOLOGY; TEA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CATECHIN; CELL CYCLE; CELL PROLIFERATION; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HCT116 CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NEOPLASTIC STEM CELLS; TEA;

EID: 84956949856     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13069     Document Type: Article

References (33)

1. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61: 69-90.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-2.
3. Fry AM. The Nek2 protein kinase: a novel regulator of centrosome structure. Oncogene 2002; 21: 6184-94.
4. Faragher AJ, Fry AM. Nek2A kinase stimulates centrosome disjunction and is required for formation of bipolar mitotic spindles. Mol. Biol. Cell 2003; 14: 2876-89.
5. Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM, Fry AM. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res. 2004; 64: 7370-6.
6. Kokuryo T, Senga T, Yokoyama Y, Nagino M, Nimura Y, Hamaguchi M. Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma. Cancer Res. 2007; 67: 9637-42.
7. Wen Z, Ye Y, Jiliang X et al. Nek2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers. Cancer Cell 2013; 23: 48-62.
8. Wang H, Xie YT, Han JY et al. Genetic polymorphisms in centrobin and Nek2 are associated with breast cancer susceptibility in a Chinese Han population. Breast Cancer Res. Treat. 2012; 136: 241-51.
9. Liu X, Gao Y, Lu Y, Zhang J, Li L, Yin F. Upregulation of NEK2 is associated with drug resistance in ovarian cancer. Oncol. Rep. 2014; 31: 745-54.
10. Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature 2012; 488: 527-30.
11. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005; 5: 275-84.
12. Du GJ, Zhang Z, Wen XD et al. Epigallocatechin gallate is the most effective cancer chemopreventive polyphenol in green tea. Nutrients 2012; 4: 1679-91.
13. Kang SU, Lee BS, Lee SH, Baek SJ, Shin YS, Kim CH. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression. J. Nutr. Biochem. 2013; 24: 986-99.
14. Koh YW, Choi EC, Kang SU, Hwang HS, Lee MH, Pyun J. Green tea epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met. J. Nutr. Biochem. 2011; 22: 1074-83.
15. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 2004; 23: 2507-22.
16. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007; 245: 232-41.
17. Graf R. DdNek2, the first non-vertebrate homologue of human Nek2, is involved in the formation of microtubule-organizing centers. J. Cell Sci. 2002; 115: 1919-29.
18. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY et al. EpCAMpositive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009; 136: 1012-24.
19. Miletti-Gonzalez KE, Chen S, Muthukumaran N et al. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res. 2005; 65: 6660-7.
20. Hou Y, Zou Q, Ge R, Shen F, Wang Y. The critical role of CD133(+)CD44 (+/high) tumor cells in hematogenous metastasis of liver cancers. Cell Res. 2012; 22: 259-72.
21. Wang D, Zhu H, Zhu Y et al. CD133(+)/CD44 (+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. Acta Histochem. 2013; 115: 349-56.
22. Shi C, Tian R, Wang M et al. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol. Ther. 2010; 10: 1182-90.
23. Okudela K, Woo T, Mitsui H, Tajiri M, Masuda M, Ohashi K. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and betacatenin, in primary lung adenocarcinoma their prognostic significance. Pathol. Int. 2012; 62: 792-801.
24. Wakamatsu Y, Sakamoto N, Oo HZ et al. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol. Int. 2012; 62: 112-9.
25. Ma S, Chan KW, Hu L et al. Identification and characterization of tumorigenic liver cancer stem cells. Gastroenterology 2007; 132: 2542-56.
26. Nishimura N, Hartomo TB, Pham TV et al. Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE (2)-C cells. Environ. Health Prev. Med. 2012; 17: 246-51.
27. Takahashi A, Watanabe T, Mondal A et al. Mechanism-based inhibition of cancer metastasis with (-)-epigallocatechin gallate. Biochem. Biophys. Res. Commun. 2014; 443: 1-6.
28. Shimizu M, Fukutomi Y, Ninomiya M et al. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev. 2008; 17: 3020-5.
29. Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 2000; 164: 82-90.
30. Gupta S, Hussain T, Mukhtar H. Molecular pathway for epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch. Biochem. Biophys. 2003; 410: 177-85.
31. Liu S, Dontu G, Wicha MS. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res. 2005; 7: 86-95.
32. Androutsellis A, Leker RR, Soldner F et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006; 442: 823-6.
33. Gardai SJ, Hildeman DA, Frankel SK et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J. Biol. Chem. 2004; 279: 21085-95.